Principales inversiones de Capital Riesgo
% ADQUIRIDO (% ALCANZADO)
DEAL VALUE €M (DEUDA ASUMIDA)
EMPRESA
INVERSOR
TIPO
ASESORES
VF: Abante Asesores CF: KPMG CL: Bufete Barrilero y Asociados
Let’s Health
Acacia Capital
p. mayoritaria
Conf.
LBO
Proclinic Group (controlada por Miura Partners) Palex Medical (controlada por Fremman Capital y Apax Partners)
Cenger Scandinavia
100%
Conf.
Build up
CL: Baker McKenzie
A Salgado Distribuçao Launch Diagnostics
CF: Dextra Corporate Finance CL: Roca Junyent
100%
Conf.
Build up
Venture Capital
Hair Up Laser
Pinama Capital
p. minoritaria
Conf.
Nina Capital Namarel Ventures aMoon Norgine Ventures Nova Capital
Venture Capital
Magentiq Eye
p. minoritaria
Conf.
CL: Garrigues DDF/Fiscal/ESG: KPMG
Longwood
Apheon
p. mayoritaria
Conf.
LBO
ACE 53 CDTI Innovación
2EyesVision
p. minoritaria
Conf.
Seed Capital
Centro Psicosanitario Galiani Orientak
Miura Partners
p. mayoritaria
Conf.
LBO
Palex Medical (controlada por Apax y Fremman)
Launch Diagnostics
100%
Conf.
Build up
CRB Inverbío Verge Impact Ventures
Venture Capital
Prosoma
p. minoritaria
Conf.
Navarra Tech Transfer Un I+D+I Technology Transfer CDTI
Medical Plasmas
p. minoritaria
Conf.
Seed Capital
ACE 53 CDTI Innovación Universal DX CDTI Innovación
Venture Capital Venture Capital
Oncovisión
p. minoritaria
Conf.
Universal Diagnostics (Universal DX) Smart Solutions Technologies (Nuubo)
p. minoritaria
Conf.
Nuubo Investments CDTI Innovación Seaya Ventures II CDTI Innovación GED Conexo Ventures Saesco Medical (controlada por Miura Partners)
p. minoritaria
Conf.
Seed Capital
Venture Capital
Savana
p. minoritaria
Conf.
VL: Garrigues
F: Aquilon Partners/AZ Capital L: Cuatrecasas CL: Deloitte DDComercial: Roland Berger F: Aquilon Partners/AZ Capital L: Cuatrecasas CL: Deloitte DDComercial: Roland Berger Financiación: BBVA
Cardiolink
100%
Conf.
Build up
Miura Partners (a través de Miura Fund IV)
Saesco Medical
p. mayoritaria
Conf.
LBO
Sociodental Boxdental Protesics Prodent Bages Laboratorio Nalón Técnica Dental Studio
Digitaldent (controlada por Alantra)
p. mayoritaria
Conf.
Build up
CF/DDF: EY
Moira Capital Partners CDTI Innovación Ysios Capital Asabys Partners (Sabadell Asabys Health Innovation Investments II y Asabys Top Up Fund) Innogest Capital II CDTI Innovación
Cella Medical Solutions
p. minoritaria
Conf.
Exp.
CL: Addleshaw Goddard
Venture Capital
Anaconda Biomed
p. minoritaria
Conf.
92
Powered by FlippingBook